Diagnostic Criteria for GERD
GERD is diagnosed either clinically through typical symptoms (heartburn, acid regurgitation) without alarm features, or objectively through endoscopic findings of erosive esophagitis (Los Angeles Grade B or higher) or abnormal esophageal acid exposure time (AET ≥6.0% on 2 or more days, or ≥4.0% meeting specific thresholds) on ambulatory pH monitoring off PPI therapy. 1, 2
Clinical Diagnosis (Unproven GERD)
For patients presenting with typical reflux symptoms (heartburn, acid regurgitation) without alarm features, a clinical diagnosis can be made and empirical PPI therapy initiated without testing 1. This approach is appropriate when:
- Typical symptoms present: Heartburn and/or acid regurgitation
- No alarm features: Absence of dysphagia, weight loss, epigastric mass, or gastrointestinal bleeding 3
Important caveat: A PPI trial is NOT appropriate for diagnosing patients with regurgitation alone, chest pain, or extraesophageal presentations (laryngitis, asthma, chronic cough) 4. These require objective testing.
Objective Diagnostic Criteria (Proven GERD)
When objective testing is needed (PPI non-responders, atypical presentations, or before anti-reflux surgery), conclusive GERD evidence includes:
Endoscopic Criteria
- Los Angeles Grade B, C, or D erosive esophagitis (Grade B is now considered conclusive, updated from prior criteria) 2
- Long-segment Barrett's esophagus (≥3 cm) 1
- Peptic stricture 2
Ambulatory pH Monitoring Criteria (Off PPI for 7 days)
Prolonged wireless pH monitoring (preferred for unproven GERD):
- AET ≥6.0% on 2 or more days = conclusive GERD 1, 2
- AET ≥4.0% but <6.0% = borderline GERD (requires clinical correlation) 1
- AET <4.0% on all days = rules out GERD 1
Standard catheter-based pH monitoring:
Borderline GERD
When findings are inconclusive, borderline GERD is diagnosed with:
- Los Angeles Grade A esophagitis, OR
- AET ≥4.0% but not meeting conclusive criteria 1
These patients may benefit from PPI therapy but require personalized management and consideration of adjunctive reflux metrics.
Diagnostic Algorithm by Clinical Scenario
Scenario 1: Typical Symptoms, No Prior Testing
- If no alarm features → empirical once-daily PPI trial for 4-8 weeks 1
- If alarm features (dysphagia, weight loss, epigastric mass) → endoscopy first 3
Scenario 2: PPI Non-Responders with Typical Symptoms
- Endoscopy first (evaluate for erosive disease, Barrett's, alternative diagnoses) 3
- If endoscopy normal or shows only LA Grade A → prolonged wireless pH monitoring off PPI 1, 2
- If pH monitoring normal → esophageal manometry to exclude achalasia, distal esophageal spasm 3
Scenario 3: Proven GERD with Persistent Symptoms on PPI
- pH-impedance monitoring ON PPI therapy to identify treatment failure mechanisms (persistent acid reflux, non-acid reflux, supragastric belching, rumination) 1, 2
Key Pitfalls to Avoid
- Do not use PPI trial to diagnose extraesophageal GERD (laryngitis, asthma) without concomitant esophageal symptoms 3
- Do not rely on alarm symptoms alone as screening tools—only dysphagia, weight loss, and epigastric mass have adequate performance for identifying malignancy 3
- Do not perform pH monitoring on PPI for initial diagnosis—normative data are unclear and interpretation is problematic 3
- Obtain ≥5 esophageal biopsies when evaluating dysphagia to exclude eosinophilic esophagitis 3
- Cardiac evaluation must precede GERD workup in chest pain presentations 3
Tests NOT Recommended for GERD Diagnosis
The following have insufficient evidence or poor diagnostic performance 4:
- Esophagram (barium swallow)
- Routine esophageal biopsies in absence of visible abnormality
- Laryngoscopy
- Pharyngeal pH monitoring